JNJ
Johnson & Johnson (JNJ) Stock Analysis
NYQ
$270.56
▼ -0.97%
Yahoo Finance chart (legacy) quote · as of Nov 2, 2026, 9:30 AM ET
$272.06
Open
$273.01
High
$267.43
Low
$273.20
Prev close
—
Market cap
Analyze JNJ in depth →
Free to try, no account needed. Create a free account for 10 analyses a day, financial statements and watchlists.
Johnson & Johnson by the reported numbers
On the most recently reported figures, Johnson & Johnson (JNJ) shows revenue up 6.0% and earnings per share up 90.5% year over year.
The business runs a net margin of 28.5%, a free cash flow margin of 20.9% and a 32.9% return on equity.
The ImpliedLens normalized earnings-value model places the shares 22.2% below the current price under its disclosed assumptions, which you can change. At today's price the market is implying 17.0% less growth than the reported figures support.
Valuation
| Forward P/E | 41.1× | Price / trailing four-quarter actual EPS · Sep 27, 2026 |
|---|---|---|
| Model upside | −22.2% | ImpliedLens normalized earnings-value model · Oct 21, 2026 |
| Conservative case | −61.4% | ImpliedLens conservative earnings-value model · Oct 21, 2026 |
| Implied growth gap | −17.0% | ImpliedLens price-expectations model · Oct 21, 2026 |
Growth
| Revenue growth | +6.0% | SEC filing · Oct 21, 2026 |
|---|---|---|
| EPS growth | +90.5% | SEC filing · Oct 21, 2026 |
| Share count change | +0.1% | SEC filing · Oct 21, 2026 |
Profitability and returns
| Net margin | 28.5% | Derived from SEC filing · Oct 21, 2026 |
|---|---|---|
| Free cash flow margin | 20.9% | SEC filing · Oct 21, 2026 |
| Return on equity | 32.9% | Derived from SEC filing · Oct 21, 2026 |
Balance sheet
| Equity / assets | 41.3% | Derived from SEC filing · Oct 21, 2026 |
|---|
Every figure above carries the source it came from and the date it was reported. Company filings as of Oct 21, 2026. Figures are reported and derived data, not advice, and the valuation model is one set of assumptions you can change.
Everything in one place
What you get with ImpliedLens.
Financial statements
Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.
DCF valuation
Customizable discounted cash flow model with live inputs.
Analyst targets
Price targets, recommendation breakdowns, earnings surprises.
Institutional context
Ownership data and aggregated FINRA OTC activity.
SEC filings
Direct links to 10-K, 10-Q, 8-K, and proxy statements.
Projection models
Bull/base/bear scenario modeling with editable assumptions.
Questions to answer before investing in JNJ
01What assumptions does the current JNJ price require to deliver an attractive return?
02Can Johnson & Johnson hold a 28.5% net margin with revenue growing 6.0% a year?
03What growth does a 41.1× forward multiple on JNJ already assume?
04Which of the model's assumptions is doing the work behind its 22.2% gap to the current JNJ price?
05Which risks would invalidate the investment thesis for JNJ?
06How does JNJ's valuation compare with its growth, quality, and closest alternatives?